| | |
| China sacks head of state asset regulator: Xinhua Monday, Sep 02, 2013 07:21 PM PDT BEIJING (Reuters) - China has sacked the head of its state assets regulator, former top energy executive Jiang Jiemin, the official Xinhua news agency said on Tuesday, two days after the agency reported Jiang was the subject of a corruption probe. Jiang is "suspected of serious discipline violations", state media said on Sunday, shorthand the government generally uses to describe graft. (Reporting by Ben Blanchard and Jonathan Standing; Editing by Paul Tait) Full Story | Top |
| Japan to spend 40 billion yen to treat radioactive water at Fukushima: Nikkei Monday, Sep 02, 2013 02:25 PM PDT | Top |
| British cost watchdog recommends Thrombogenics eye drug Monday, Sep 02, 2013 09:00 AM PDT BRUSSELS (Reuters) - Belgian biotech group Thrombogenics said on Monday that its main drug Jetrea, which treats eye disease, was recommended for reimbursement by British healthcare cost watchdog NICE. Jetrea, which treats vitreomacular adhesion, an ageing-related vision problem that can lead to blindness, was recommended for full reimbursement, also for those patients with early stage symptoms, Thrombogenics said. (Reporting by Robert-Jan Bartunek) Full Story | Top |
| Libya imports fuel to keep the power on Monday, Sep 02, 2013 05:43 AM PDT TRIPOLI (Reuters) - Libya has begun importing diesel and fuel oil to keep power plants operating after protests closed most of the gas fields in its eastern region which usually supply them, an industry executive said on Monday. No end is in sight to the worst disruption to Libya's oil industry since the civil war in 2011 as armed groups, security guards and oil workers with tribal loyalties shut down pipelines and oil ports across the country. ... Full Story | Top |
| Novartis heart failure drug effective across patient groups Monday, Sep 02, 2013 05:00 AM PDT By Ben Hirschler AMSTERDAM (Reuters) - An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug, serelaxin, which is a form of a human hormone that relaxes blood vessels and eases stress on the heart and other organs, is viewed as an important medicine in the Swiss drugmaker's developmental pipeline. Analysts at Jefferies expect the drug to generate peak sales of $1.5 billion a year. ... Full Story | Top |
| Doctors get good and bad safety news on diabetes drugs Monday, Sep 02, 2013 02:53 AM PDT By Ben Hirschler AMSTERDAM (Reuters) - Diabetes pills known as DPP-4 therapies got a mixed safety report on Monday as studies showed they did not raise the risk of heart attacks but might be linked to heart failure, where the heart fails to pump blood adequately. Reassuringly, the medicines were not associated with increased rates of either inflammation of the pancreas or cancer - something that has been a worry in the past. However, in the case of AstraZeneca and Bristol-Myers Squibb's approved drug Onglyza, there was a small increase in hospitalizations for heart failure. ... Full Story | Top |
| Ivory Coast's SMB revamps refinery, eyes local market Monday, Sep 02, 2013 02:44 AM PDT ABIDJAN (Reuters) - Ivory Coast bitumen maker SMB produced 216,000 tonnes last year but will see output dip by more than 30 percent in 2013 owing to work on its refinery, its chairwoman said on Friday. Aminata Traore told Reuters that output should climb to 275,000 tonnes by 2015, with post-war reconstruction making Ivory Coast a growing market despite stiff competition from Asian and European producers. SMB is West Africa's sole producer of bitumen, which is used in road construction. Traore said Nigeria was its biggest single market, with Angola second. ... Full Story | Top |
| Japan vows quick action, public funds for Fukushima Monday, Sep 02, 2013 01:22 AM PDT | Top |
| OMV says gets stake in Madagascar offshore block Monday, Sep 02, 2013 12:13 AM PDT | Top |
| Mexico Lower House approves final part of divisive education reform Sunday, Sep 01, 2013 09:57 PM PDT MEXICO CITY (Reuters) - Mexican lawmakers on Sunday approved the final part of a bill to reform an education sector that badly underperforms global peers, legislation that has prompted thousands of school staff to protest in the streets. The lower house approved so-called secondary laws that regulate the tests that President Enrique Pena Nieto says teachers should take periodically to ensure they are up to standard or lose their jobs should they flunk. ... Full Story | Top |
| Japan reiterates may consider discharging radiated Fukushima water into ocean Sunday, Sep 01, 2013 09:30 PM PDT | Top |
|

No comments:
Post a Comment